0000061398 false 0000061398 2022-04-07 2022-04-07 0000061398 us-gaap:CommonStockMember 2022-04-07 2022-04-07 0000061398 tell:SeniorNotes8.25PercentDue2028Member 2022-04-07 2022-04-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):           April 7, 2022

  

 

 

Tellurian Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-5507   06-0842255
(State or other jurisdiction of
incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

1201 Louisiana Street, Suite 3100, Houston, TX   77002
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:        (832) 962-4000  

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.01 per share   TELL   NYSE American LLC
         
8.25% Senior Notes due 2028   TELZ   NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 1.01Entry Into a Material Definitive Agreement.

 

On December 17, 2021, Tellurian Inc., a Delaware corporation (the “Company”), entered into a Distribution Agency Agreement (the “Distribution Agreement”) with T.R. Winston & Company, LLC (“T.R. Winston”). Pursuant to the terms of the Distribution Agreement, the Company may sell shares of its common stock, $0.01 par value per share, from time to time on the NYSE American or any other market for the common stock in the United States with T.R. Winston acting as agent (the “Equity Offering”). Under the Distribution Agreement as initially entered into, the maximum aggregate sales proceeds of the Equity Offering was $200,000,000. On April 7, 2022, the Company and T.R. Winston entered into an amendment to the Distribution Agreement pursuant to which the maximum aggregate sales proceeds of the Equity Offering was increased to $400,000,000. The terms of the Distribution Agreement, which were not otherwise changed by the amendment, are summarized in the Company’s Current Report on Form 8-K filed on December 17, 2021, which summary is incorporated by reference herein.

 

Item 9.01Financial Statements and Exhibits.

 

(d)       Exhibits.

 

Exhibit
No.
  Description
1.1   Distribution Agreement, dated as of December 17, 2021, by and between Tellurian Inc. and T.R. Winston & Company, LLC (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on December 17, 2021).  
1.2   Amendment to Distribution Agreement, dated as of April 7, 2022, by and between Tellurian Inc. and T.R. Winston & Company, LLC.
5.1   Opinion of Davis Graham & Stubbs LLP.  
104   Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document (included as Exhibit 101)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TELLURIAN INC.
   
     
  By: /s/ L. Kian Granmayeh
  Name: L. Kian Granmayeh
  Title: Executive Vice President and Chief Financial Officer

 

Date: April 7, 2022

 

 

 

 

Exhibit 1.2

 

T.R. Winston & Company, LLC

2049 Century Park East, Suite 320

Los Angeles, California 90067

 

April 7, 2022

 

Tellurian Inc.

1201 Louisiana Street, Suite 3100

Houston, TX 77002

 

Re:Distribution Agency Agreement dated December 17, 2021 (the “Sales Agreement”), between T.R. Winston & Company, LLC (“T.R. Winston”) and Tellurian Inc. (the “Company”).

 

Dear Sirs:

 

Section 1 of the Sales Agreement is hereby amended and restated in its entirety as follows:

 

“Introduction. Tellurian Inc., a Delaware corporation (the “Company”), agrees with T.R. Winston & Company, LLC (the “Manager”) to issue and sell from time to time through the Manager, as sales agent, shares of its common stock, $0.01 par value (the “Common Stock”), having an aggregate offering price of up to $400,000,000 (the “Maximum Amount”) on the terms set forth herein. The shares of Common Stock to be issued and sold hereunder shall be referred to as the “Shares.””

 

This amendment and restatement will be deemed effective as of the date of this letter agreement.

 

Except as set forth above, the Sales Agreement shall remain in effect in all respects.

 

This letter agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws.

 

If the foregoing correctly sets forth the understanding between the Company and T.R. Winston please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and T.R. Winston.

 

 

 

 

  T.R. WINSTON & COMPANY, LLC.
   
  By:     /s/ Karen Kang
  Name: Karen Kang
  Title: Partner

 

 

Acknowledged and agreed:

 

TELLURIAN INC.

 

 

By: /s/ L. Kian Granmayeh  
Name: L. Kian Granmayeh  
Title: Chief Financial Officer  

 

 

 

 

Exhibit 5.1

 

 

 

April 7, 2022

 

Board of Directors

Tellurian Inc.

1201 Louisiana Street, Suite 3100

Houston, Texas 77002

 

Ladies and Gentlemen:

 

We have acted as counsel to Tellurian Inc., a Delaware corporation (the “Company”), in connection with the filing by the Company of a prospectus supplement dated April 7, 2022 (the “Prospectus Supplement”), which supplements the Company’s Registration Statement (the “Registration Statement”) on Form S-3ASR (Registration No. 333-235793) filed on January 3, 2020 with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), as amended by Post-effective Amendment No. 1 on April 28, 2020, including the Prospectus dated April 28, 2020 included therein (together with the Prospectus Supplement, the “Prospectus”), relating to the offer and sale of up to $400,000,000 of shares of the Company’s common stock, par value $0.01 per share (the “Shares”).

 

The Shares are to be issued pursuant to the Prospectus and a Distribution Agency Agreement, dated as of December 17, 2021 and amended as of April 7, 2022, between the Company and T.R. Winston & Company, LLC (the “Distribution Agreement”).

 

In rendering the opinions set forth below, we have reviewed the Registration Statement, the Prospectus and the Distribution Agreement. We have also examined the originals, or duplicates or certified or conformed copies, of such corporate and other records, agreements, documents and other instruments and have made such other investigations as we deemed relevant and necessary in respect of the authorization and issuance of the Shares, and such other matters as we deemed appropriate. In such examination, we have assumed the genuineness of all signatures, the authority of each person signing in a representative capacity (other than the Company) any document reviewed by us, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, and the authenticity of the originals of such documents. In conducting our examination of documents, we have assumed the power, corporate or other, of all parties thereto other than the Company to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the due execution and delivery by such parties of such documents and that to the extent such documents purport to constitute agreements, such documents constitute valid and binding obligations of such parties. As to any facts material to our opinion, we have made no independent investigation of such facts and have relied, to the extent that we deem such reliance proper, upon certificates of public officials and officers or other representatives of the Company.

 

 

 

 

 

Tellurian Inc.

April 7, 2022

Page 2

 

Based upon the foregoing, and subject to the limitations, qualifications, exceptions and assumptions expressed herein, we are of the opinion that the Shares, when and to the extent issued and paid for in the manner described in the Registration Statement and the Prospectus and in accordance with the terms of the Distribution Agreement and the resolutions adopted by the Board of Directors of the Company and the Pricing Committee thereof, will be duly authorized, validly issued, fully paid and non-assessable.

 

We are members of the Bar of the State of Colorado. Our examination of matters of law in connection with the opinions set forth below has been limited to, and accordingly our opinions herein are limited to, the General Corporation Law of the State of Delaware, including all applicable provisions of the Delaware Constitution and reported judicial decisions interpreting such law. We express no opinion with respect to the laws of any other jurisdiction or of any other law of the State of Delaware.

 

This opinion is given as of the date hereof and we have no obligation to update this opinion to take into account any change in applicable law or facts that may occur after the date hereof. We hereby consent to the filing of this opinion as an exhibit to the Current Report on Form 8-K filed by the Company on the date hereof and to be named in the Prospectus as the attorneys who will pass upon legal matters in connection with the issuance of the Shares. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act and the rules and regulations of the Commission thereunder.

 

  Very truly yours,
   
  /s/ DAVIS GRAHAM & STUBBS LLP
   
  DAVIS GRAHAM & STUBBS LLP